Mark H. Gotfried
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 50
- Pneumonia and Respiratory Infections 42
-
- Respiratory and Cough-Related Research 17
- Chronic Obstructive Pulmonary Disease (COPD) Research 15
- Respiratory Support and Mechanisms 9
- Cystic Fibrosis Research Advances 8
- Co-authors
- Keith A. Rodvold (24 shared papers)Larry H. Danziger (10 shared papers)Ronald J. Servi (4 shared papers)Joan Korth‐Bradley (2 shared papers)Gary Dukart (2 shared papers)Evelyn J. Ellis‐Grosse (2 shared papers)Mary Cwik (1 shared paper)George L. Drusano (4 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (20 papers)CHEST Journal (8 papers)Clinical Therapeutics (5 papers)American Journal of Respiratory and Critical Care Medicine (3 papers)European Respiratory Journal (3 papers)
- Partner nations
- United StatesAustriaUnited Kingdom
In The Last Decade
Mark H. Gotfried
82 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 111
- Molecular Medicine 988
- Applied Microbiology and Biotechnology 202
- Pharmacology 1.2k
- Pulmonary and Respiratory Medicine 1.4k
- Epidemiology 1.3k
Countries citing papers authored by Mark H. Gotfried
This map shows the geographic impact of Mark H. Gotfried's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark H. Gotfried with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark H. Gotfried more than expected).
Fields of papers citing papers by Mark H. Gotfried
This network shows the impact of papers produced by Mark H. Gotfried. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark H. Gotfried. The network helps show where Mark H. Gotfried may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark H. Gotfried, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 242 | |
| 2 | 2000 | 239 | |
| 3 | 1997 | 162 | |
| 4 | 2001 | 140 | |
| 5 | 2006 | 119 | |
| 6 | 2018 | 111 | |
| 7 | 2017 | 110 | |
| 8 | 2004 | 107 | |
| 9 | 2012 | 106 | |
| 10 | 2011 | 99 | |
| 11 | 2015 | 96 | |
| 12 | 2005 | 94 | |
| 13 | 2003 | 94 | |
| 14 | 2003 | 92 | |
| 15 | 2009 | 73 | |
| 16 | 2009 | 68 | |
| 17 | 2018 | 66 | |
| 18 | 2007 | 63 | |
| 19 | 2018 | 61 | |
| 20 | 2014 | 58 |
About Mark H. Gotfried
Mark H. Gotfried is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine, Pharmacology, Physiology and Molecular Medicine, having authored 87 papers that have together received 3.4k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (42 papers), Antibiotics Pharmacokinetics and Efficacy (34 papers), Respiratory and Cough-Related Research (17 papers), Antibiotic Resistance in Bacteria (17 papers), Asthma and respiratory diseases (16 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers), Respiratory Support and Mechanisms (9 papers) and Cystic Fibrosis Research Advances (8 papers). The work is most often cited by research in Molecular Medicine (988 citations), Applied Microbiology and Biotechnology (202 citations), Pharmacology (1.2k citations), Pulmonary and Respiratory Medicine (1.4k citations) and Epidemiology (1.3k citations). Mark H. Gotfried has collaborated with scholars based in United States, Austria and United Kingdom. Frequent co-authors include Keith A. Rodvold, Larry H. Danziger, Ronald J. Servi, Joan Korth‐Bradley, Gary Dukart, Evelyn J. Ellis‐Grosse, Mary Cwik, George L. Drusano, Noreen Henig and Diana Bilton. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, CHEST Journal, Clinical Therapeutics, American Journal of Respiratory and Critical Care Medicine and European Respiratory Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.